MORGAN STANLEY PLC/PUT/ELI LILLY & CO/600/0.01/20.09.24 | Market Closed - Bid/Ask 09:50:09 01/07/2024 pm IST | After market 12:20:55 am | |||
| 0.022 EUR | +22.22% |
|
0.031 | +40.91% |
| Current month | -47.06% | ||
| 1 month | -47.06% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
| Date | Price | Change |
|---|---|---|
| 01/24/01 | 0.022 | +22.22% |
| 28/24/28 | 0.018 | -5.26% |
| 27/24/27 | 0.019 | -5.00% |
| 26/24/26 | 0.02 | 0.00% |
| 25/24/25 | 0.02 | +5.26% |
Delayed Quote Börse Stuttgart
Last update July 01, 2024 at 09:50 pm IST
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | Morgan Stanley |
| WKN | ME1Z7Z |
| ISIN | DE000ME1Z7Z3 |
| Date issued | 12/10/2023 |
| Strike | 600 $ |
| Maturity | 20/09/2024 (81 Days) |
| Parity | 100 : 1 |
| Emission price | 0.72 € |
| Emission volume | N/A |
| Settlement | Por diferencias |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.88 € |
|---|---|
| Lowest since issue | 0.016 € |
| Delta | -0.03x |
| Omega | 9.184 |
| Premium | 34.64x |
| Gearing | 274.52x |
| Moneyness | 0.6573 |
| Difference Strike | -313.7 $ |
| Difference Strike % | -52.29% |
| Spread | 0.018 € |
| Spread % | 45.00% |
| Theoretical value | 0.0310 |
| Implied Volatility | 53.20 % |
| Total Loss Probability | 94.33 % |
| Intrinsic value | 0.000000 |
| Present value | 0.0310 |
| Break even | 596.67 € |
| Theta | -0.01x |
| Vega | 0x |
| Rho | -0x |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
905.4
USD
Average target price
868.9
USD
Spread / Average Target
-4.03%
- Stock Market
- Warrants
- Warrant
